#canine osteosarcoma

Osteosarcoma: Beyond amputation and euthanasia

March 12, 2019

When a patient is diagnosed with osteosarcoma, we tend to focus on three options: • the “gold standard,” i.e. amputation with or without chemotherapy; • what many call palliative care, meaning pain medication and rest; or • euthanasia. But what if amputation is not an option? What if chemotherapy or radiation is out of the owner’s financial capabilities? Or a couple of medications are not enough to numb the pain? What if …

20-plus clinics to participate in expanded osteosarcoma vaccine clinical trial

September 6, 2018

Initial results of a pilot study for canine osteosarcoma vaccine are promising, prompting a larger study to test its safety and efficacy. Pharmaceutical company Aratana Therapeutics, which received conditional licensure for Live Listeria Vector (AT-014), has expanded its clinical trial to include more than two dozen veterinary oncology practice groups across the U.S. in order to receive full licensure. Conducted by the University of Pennsylvania School of Veterinary Medicine, the pilot study tested the immunotherapy …

ELIAS presents preliminary canine osteosarcoma results at ACVIM

August 3, 2018

During the 2018 American College of Veterinary Internal Medicine Forum in June, ELIAS Animal Health, a clinical stage development company advancing novel treatments for companion animal cancer, shared preliminary canine osteosarcoma results for its cancer immunotherapy. According to study results presented by Brian Flesner, DVM, DACVIM (Oncology), University of Missouri, the company’s new ELIAS autologous cancer vaccine, featuring a patented vaccine and T cell infusion combination approach, demonstrated “impressive survival times and minimal side …

Canadian researchers team up to fight canine osteosarcoma

June 14, 2018

A group of researchers called the Dog Osteosarcoma Group–Biomarkers of Neoplasia (DOGBONe) at the University of Guelph in Ontario, Canada, have joined forces to determine more accurate ways of measuring bone cancer, with the main objective of identifying biomarkers to assess patients with canine osteosarcoma. The presentation of osteosarcoma in dogs is remarkably similar to that of humans, according to the Ontario Veterinary College (OVC); so much so that computers are unable to distinguish …

MAF awards Penn $775K to test osteosarcoma immunotherapy vaccine in dogs

April 20, 2018

Morris Animal Foundation (MAF) has awarded a $775,000 grant to the University of Pennsylvania to test a vaccine that could improve longevity and quality of life for dogs with osteosarcoma. The research team will conduct clinical trials to evaluate a novel immunotherapy treatment that combines a molecule expressed by cancer cells with a modified live form of Listeria monocytogenes. A pilot study demonstrated this combination elicited a powerful, targeted immune response directed …
New on

Join VPN Plus+ today to get access to exclusive content like:

A captive audience: The power of digital communication
Lighten the financial load—Why debt consolidation may be the answer
When bad reviews happen to good veterinarians
Paper versus paperless: What is best for your practice?
Join Now!
COVID-19
Post-pandemic social media marketing: What do you need to know?
Surviving a pandemic as a veterinary professional
Seven pet care tips for owners returning to work
New guidelines help ensure heartworm safety, prevention amid COVID-19
Thousands of specimens show no evidence of COVID-19 in pets